Ifrah Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Sell
7,294
-37
-0.5% -$7.96K 0.45% 49
2026
Q1
$1.59M Sell
7,331
-230
-3% -$51K 0.42% 50
2025
Q4
$1.73M Sell
7,561
-195
-3% -$44.4K 0.44% 47
2025
Q3
$1.8M Buy
7,756
+173
+2% +$35.2K 0.47% 48
2025
Q2
$1.41M Sell
7,583
-60
-0.8% -$11.2K 0.38% 52
2025
Q1
$1.6M Sell
7,643
-478
-6% -$92.9K 0.46% 46
2024
Q4
$1.44M Sell
8,121
-198
-2% -$36.4K 0.4% 52
2024
Q3
$1.64M Buy
8,319
+112
+1% +$20.9K 0.44% 49
2024
Q2
$1.41M Sell
8,207
-677
-8% -$112K 0.4% 53
2024
Q1
$1.62M Sell
8,884
-20,204
-69% -$3.48M 0.45% 51
2023
Q4
$4.51M Sell
29,088
-443
-2% -$64.6K 1.32% 24
2023
Q3
$4.4M Sell
29,531
-58
-0.2% -$8.52K 1.37% 21
2023
Q2
$3.99M Sell
29,589
-40
-0.1% -$5.87K 1.21% 25
2023
Q1
$4.72M Sell
29,629
-200
-0.7% -$30.6K 1.5% 17
2022
Q4
$4.82M Sell
29,829
-228
-0.8% -$35K 1.58% 17
2022
Q3
$4.03M Sell
30,057
-73
-0.2% -$10.5K 1.39% 21
2022
Q2
$4.62M Sell
30,130
-1,533
-5% -$234K 1.5% 17
2022
Q1
$5.13M Buy
31,663
+186
+0.6% +$27K 1.44% 21
2021
Q4
$4.26M Buy
31,477
+7
+0% +$827 1.14% 26
2021
Q3
$3.4M Buy
31,470
+17
+0.1% +$1.94K 0.98% 31
2021
Q2
$3.54M Sell
31,453
-307
-1% -$34.6K 1.01% 30
2021
Q1
$3.44M Sell
31,760
-455
-1% -$48.7K 1.03% 29
2020
Q4
$3.45M Sell
32,215
-169
-0.5% -$16.2K 1.11% 25
2020
Q3
$2.84M Buy
32,384
+445
+1% +$41.9K 1.02% 30
2020
Q2
$3.14M Sell
31,939
-358
-1% -$31.5K 1.14% 25
2020
Q1
$2.46M Sell
32,297
-9
-0% -$767 1.03% 30
2019
Q4
$2.86M Sell
32,306
-295
-0.9% -$24.5K 1.01% 31
2019
Q3
$2.47M Sell
32,601
-236
-0.7% -$16.2K 0.9% 32
2019
Q2
$2.39M Sell
32,837
-188
-0.6% -$14.8K 0.88% 32
2019
Q1
$2.66M Sell
33,025
-127
-0.4% -$10.4K 1.01% 31
2018
Q4
$3.06M Sell
33,152
-454
-1% -$39.9K 1.29% 26
2018
Q3
$3.18M Sell
33,606
-353
-1% -$33.5K 1.12% 27
2018
Q2
$3.15M Sell
33,959
-15
-0% -$1.47K 1.14% 27
2018
Q1
$3.22M Sell
33,974
-1,032
-3% -$113K 1.17% 25
2017
Q4
$3.38M Buy
35,006
+55
+0.2% +$5.18K 1.23% 25
2017
Q3
$3.11M Sell
34,951
-99
-0.3% -$7.54K 1.18% 26
2017
Q2
$2.54M Sell
35,050
-152
-0.4% -$10.2K 1% 29
2017
Q1
$2.29M Sell
35,202
-316
-0.9% -$19.9K 0.92% 29
2016
Q4
$2.22M Sell
35,518
-5,320
-13% -$325K 0.91% 30
2016
Q3
$2.58M Buy
40,838
+20,838
+104% +$1.35M 1.03% 29
2016
Q2
$1.24M Hold
20,000
0.49% 38
2016
Q1
$1.14M Hold
20,000
0.46% 42
2015
Q4
$1.19M Hold
20,000
0.47% 46
2015
Q3
$1.09M Hold
20,000
0.44% 45
2015
Q2
$1.34M Hold
20,000
0.5% 40
2015
Q1
$1.17M Sell
20,000
-2,246
-10% -$136K 0.44% 46
2014
Q4
$1.46M Sell
22,246
-146
-0.7% -$9.2K 0.57% 39
2014
Q3
$1.29M Sell
22,392
-34
-0.2% -$1.89K 0.5% 39
2014
Q2
$1.27M Sell
22,426
-198
-0.9% -$10.4K 0.48% 39
2014
Q1
$1.16M Sell
22,624
-111
-0.5% -$5.61K 0.46% 43
2013
Q4
$1.2M Sell
22,735
-70
-0.3% -$3.44K 0.48% 40
2013
Q3
$1.02M Sell
22,805
-73
-0.3% -$3.24K 0.49% 42
2013
Q2
$946K Buy
+22,878
New +$1M 0.48% 43

Other funds holding ABBV

Ifrah Financial Services's ABBV Position: Q2 2026 in Review

Ifrah Financial Services reduced its AbbVie (ABBV) stake by 0.5% in Q2 2026, selling an estimated $7.96K and leaving 7,294 shares worth $1.84M. The position accounts for 0.45% of the portfolio, ranked #49.

Ifrah Financial Services first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.13M in Q1 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ifrah Financial Services held 7,294 shares of AbbVie worth $1.84M as of Q2 2026.
  • Ifrah Financial Services sold 37 AbbVie shares in Q2 2026, an estimated $7.96K.
  • AbbVie made up 0.45% of Ifrah Financial Services's portfolio in Q2 2026, its #49 holding.
  • Ifrah Financial Services first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Ifrah Financial Services's AbbVie position peaked at $5.13M in Q1 2022.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ifrah Financial Services's 13F filing for Q2 2026, filed 21 Jul 2026.